Neoleukin

Neoleukin is a biopharmaceutical company that has historically leveraged novel protein design technology to create next-generation immunotherapies for the treatment of cancer, inflammation, and autoimmune diseases. Neoleukin has developed sophisticated computational methods to design proteins that exhibit specific drug-like properties, potentially offering superior therapeutic benefits compared to native proteins.